# Olanzapine Versus Lithium in the Treatment of Acute Depression in Patients With Bipolar II or Bipolar Not Otherwise Specified(OL Study)

> **NCT02287259** · PHASE4 · COMPLETED · sponsor: **Tadashi Hasegawa** · enrollment: 50 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** olanzapine
- **DRUG:** lithium

## Key facts

- **NCT ID:** NCT02287259
- **Lead sponsor:** Tadashi Hasegawa
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2019-03-31
- **Final completion:** 2019-03-31
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2019-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02287259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02287259, "Olanzapine Versus Lithium in the Treatment of Acute Depression in Patients With Bipolar II or Bipolar Not Otherwise Specified(OL Study)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02287259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*